• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过Toll样受体(TLR)激动剂增强急性髓系白血病(AML)原始细胞对自体T细胞的反应性。

Augmentation of autologous T cell reactivity with acute myeloid leukemia (AML) blasts by Toll-like receptor (TLR) agonists.

作者信息

Zhong RuiKun, Li Hongying, Messer Karen, Lane Thomas A, Zhou Jiehua, Ball Edward D

机构信息

Division of Blood and Marrow Transplantation, Departments of Medicine, Pathology and the Moores UCSD Cancer Center, University of California, San Diego, 3855 Health Sciences Drive, La Jolla, CA, 92093-0960, USA.

出版信息

Cancer Immunol Immunother. 2015 Jun;64(6):737-44. doi: 10.1007/s00262-015-1680-x. Epub 2015 Mar 21.

DOI:10.1007/s00262-015-1680-x
PMID:25795133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4742236/
Abstract

This study investigated whether TNF-α, Toll-like receptors (TLRs) 7/8 agonist resiquimod (R848), the TLR4 agonist lipopolysaccharide (LPS) and their combinations can enhance autologous AML-reactive T cell generation in an in vitro culture. AML peripheral blood or bone marrow mononuclear cells were cultured in medium supplemented with GM-CSF/IL-4 to induce dendritic cell (DC) differentiation of AML blasts (AML-DC). The impact of TNF-α, LPS, R848 and their combinations on AML-DC cultures was analyzed. Significantly enhanced CD80, CD40, CD83, CD54, HLA-DR and CD86 expression of AML cells was observed by addition of TNF-α, LPS, R848 alone or combinations. Induced CD80 expression of AML cells was significantly higher through the combination of TNF-α, LPS and R848 (T + L + R) than that by T alone. CTL induced from T + L + R, T + R, T + L, L + R and R, but not T, L alone stimulated cultures showed significantly higher IFN-γ release than the medium control in response to autologous AML cells. IFN-γ release by T + L + R was significantly higher than T or L alone, and T + R was significantly higher than T alone. CTL generated from T + L + R, T + L, T + R, L + R and L alone exerted significantly higher AML cell killing than medium control. AML cell killing by T + L + R and T + R was significantly higher than T or R alone. These results indicate that the combination of T + L + R induces a significantly enhanced antigen presentation effect of AML-DC. We speculate that the complementary effects of reagent combinations may better address the heterogeneity of responses to any single agent in AML cells from different patients.

摘要

本研究调查了肿瘤坏死因子-α(TNF-α)、Toll样受体(TLR)7/8激动剂瑞喹莫德(R848)、TLR4激动剂脂多糖(LPS)及其组合是否能在体外培养中增强自体抗急性髓系白血病(AML)反应性T细胞的生成。将AML外周血或骨髓单个核细胞在补充有粒细胞-巨噬细胞集落刺激因子(GM-CSF)/白细胞介素-4(IL-4)的培养基中培养,以诱导AML原始细胞分化为树突状细胞(AML-DC)。分析了TNF-α、LPS、R848及其组合对AML-DC培养物的影响。单独添加TNF-α、LPS、R848或其组合后,观察到AML细胞的CD80、CD40、CD83、CD54、人类白细胞抗原-DR(HLA-DR)和CD86表达显著增强。通过TNF-α、LPS和R848(T+L+R)组合诱导的AML细胞CD80表达显著高于单独使用T诱导的表达。从T+L+R、T+R、T+L、L+R和R诱导产生的细胞毒性T淋巴细胞(CTL),但不是单独的T、L刺激培养物,在对自体AML细胞的反应中显示出比培养基对照显著更高的γ干扰素(IFN-γ)释放。T+L+R释放的IFN-γ显著高于单独的T或L,T+R显著高于单独的T。从T+L+R、T+L、T+R、L+R和单独的L产生的CTL对AML细胞的杀伤作用显著高于培养基对照。T+L+R和T+R对AML细胞的杀伤作用显著高于单独的T或R。这些结果表明,T+L+R组合可显著增强AML-DC的抗原呈递效应。我们推测,试剂组合的互补效应可能更好地应对来自不同患者的AML细胞对任何单一试剂反应的异质性。

相似文献

1
Augmentation of autologous T cell reactivity with acute myeloid leukemia (AML) blasts by Toll-like receptor (TLR) agonists.通过Toll样受体(TLR)激动剂增强急性髓系白血病(AML)原始细胞对自体T细胞的反应性。
Cancer Immunol Immunother. 2015 Jun;64(6):737-44. doi: 10.1007/s00262-015-1680-x. Epub 2015 Mar 21.
2
In vitro induction of potent tumor-specific cytotoxic T lymphocytes using TLR agonist-activated AML-DC.利用 TLR 激动剂激活的 AML-DC 体外诱导强效的肿瘤特异性细胞毒性 T 淋巴细胞。
Target Oncol. 2014 Sep;9(3):225-37. doi: 10.1007/s11523-013-0285-6. Epub 2013 Jul 14.
3
Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.急性髓系白血病患者原始细胞来源的树突状细胞中Toll样受体-2、-4和-9的定量表达
Transfusion. 2008 May;48(5):861-70. doi: 10.1111/j.1537-2995.2007.01616.x. Epub 2008 Jan 15.
4
CTLA-4 blockade by a human MAb enhances the capacity of AML-derived DC to induce T-cell responses against AML cells in an autologous culture system.人源单克隆抗体阻断CTLA-4可增强急性髓系白血病来源的树突状细胞在自体培养系统中诱导针对急性髓系白血病细胞的T细胞反应的能力。
Cytotherapy. 2006;8(1):3-12. doi: 10.1080/14653240500499507.
5
[Investigation on specific killing acute leukemia cell reaction of the cytotoxic T lymphocyte induced by dendritic cell pulsed with frozen-thawed antigen].[冻融抗原负载树突状细胞诱导的细胞毒性T淋巴细胞特异性杀伤急性白血病细胞反应的研究]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2004 Dec;21(6):974-8.
6
Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells.Toll 样受体激动剂通过调节单核细胞衍生的树突状细胞增强 HPV11 E7 特异性 T 细胞反应。
Arch Dermatol Res. 2010 Jan;302(1):57-65. doi: 10.1007/s00403-009-0976-0. Epub 2009 Jul 4.
7
[T-cell immunity against autologous leukemic cell mediated by in vitro bone marrow-derived dendritic cell from patients with acute myeloid leukemia in complete remission].[完全缓解的急性髓系白血病患者体外骨髓来源树突状细胞介导的针对自体白血病细胞的T细胞免疫]
Zhonghua Xue Ye Xue Za Zhi. 2001 Dec;22(12):629-32.
8
Role of Interferon (IFN)α in "Cocktails" for the Generation of (Leukemia-derived) Dendritic Cells (DCleu) From Blasts in Blood From Patients (pts) With Acute Myeloid Leukemia (AML) and the Induction of Antileukemic Reactions.干扰素(IFN)α 在“鸡尾酒”中作用于急性髓系白血病(AML)患者血液中的原始细胞,生成白血病来源的树突状细胞(DCleu),并诱导抗白血病反应。
J Immunother. 2019 Jun;42(5):143-161. doi: 10.1097/CJI.0000000000000266.
9
Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cells.通过急性髓系白血病单核细胞的竞争性有限稀释培养产生针对自体急性髓系白血病细胞的T细胞系。
Exp Hematol. 2008 Apr;36(4):486-94. doi: 10.1016/j.exphem.2007.11.012. Epub 2008 Jan 30.
10
Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage.急性髓性白血病中CD86的表达是树突状细胞/单核细胞系的一个标志物。
Exp Hematol. 2002 Feb;30(2):126-34. doi: 10.1016/s0301-472x(01)00768-8.

引用本文的文献

1
TLR7/8 ligands R848 and imiquimod induce differentiation of bone marrow cells from patients with myelodysplastic syndrome towards mature neutrophils.Toll样受体7/8(TLR7/8)配体R848和咪喹莫特可诱导骨髓增生异常综合征患者的骨髓细胞向成熟中性粒细胞分化。
Sci Rep. 2025 Aug 26;15(1):31496. doi: 10.1038/s41598-025-15859-z.
2
The Role of TRL7/8 Agonists in Cancer Therapy, with Special Emphasis on Hematologic Malignancies.TRL7/8激动剂在癌症治疗中的作用,尤其着重于血液系统恶性肿瘤
Vaccines (Basel). 2023 Jan 28;11(2):277. doi: 10.3390/vaccines11020277.
3
Contribution of Aberrant Toll Like Receptor Signaling to the Pathogenesis of Myelodysplastic Syndromes.异常 Toll 样受体信号在骨髓增生异常综合征发病机制中的作用。
Front Immunol. 2020 Jun 17;11:1236. doi: 10.3389/fimmu.2020.01236. eCollection 2020.
4
Functional Toll-Like Receptors (TLRs) Are Expressed by a Majority of Primary Human Acute Myeloid Leukemia Cells and Inducibility of the TLR Signaling Pathway Is Associated with a More Favorable Phenotype.大多数原发性人类急性髓系白血病细胞表达功能性Toll样受体(TLR),且TLR信号通路的可诱导性与更有利的表型相关。
Cancers (Basel). 2019 Jul 11;11(7):973. doi: 10.3390/cancers11070973.
5
Imiquimod inhibits growth and induces differentiation of myeloid leukemia cell lines.咪喹莫特抑制髓系白血病细胞系的生长并诱导其分化。
Cancer Cell Int. 2018 Jan 30;18:15. doi: 10.1186/s12935-018-0515-1. eCollection 2018.
6
Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells.白血病前期和白血病干细胞中的炎症信号通路
Front Oncol. 2017 Nov 13;7:265. doi: 10.3389/fonc.2017.00265. eCollection 2017.
7
Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications.髓系恶性肿瘤中的间充质干细胞:聚焦免疫逃逸及治疗意义
Stem Cells Int. 2017;2017:6720594. doi: 10.1155/2017/6720594. Epub 2017 Aug 21.
8
The Novel Toll-Like Receptor 2 Agonist SUP3 Enhances Antigen Presentation and T Cell Activation by Dendritic Cells.新型Toll样受体2激动剂SUP3增强树突状细胞的抗原呈递和T细胞活化。
Front Immunol. 2017 Feb 21;8:158. doi: 10.3389/fimmu.2017.00158. eCollection 2017.
9
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?正常和发育异常造血中的间充质干细胞和祖细胞——生存与克隆性的主宰?
Int J Mol Sci. 2016 Jun 27;17(7):1009. doi: 10.3390/ijms17071009.

本文引用的文献

1
Cytotoxic T cells induce proliferation of chronic myeloid leukemia stem cells by secreting interferon-γ.细胞毒性 T 细胞通过分泌干扰素-γ诱导慢性髓性白血病干细胞增殖。
J Exp Med. 2013 Mar 11;210(3):605-21. doi: 10.1084/jem.20121229. Epub 2013 Feb 11.
2
Hematopoiesis sculpted by pathogens: Toll-like receptors and inflammatory mediators directly activate stem cells.病原体塑造造血:Toll 样受体和炎症介质直接激活干细胞。
Cytokine. 2012 Jan;57(1):1-8. doi: 10.1016/j.cyto.2011.10.005. Epub 2011 Nov 12.
3
Toll-like receptors in angiogenesis.血管生成中的Toll样受体。
ScientificWorldJournal. 2011 Apr 19;11:981-91. doi: 10.1100/tsw.2011.92.
4
Acute myeloid leukemia.急性髓系白血病。
Hematol Oncol Clin North Am. 2010 Feb;24(1):35-63. doi: 10.1016/j.hoc.2009.11.008.
5
A cell biological view of Toll-like receptor function: regulation through compartmentalization.Toll样受体功能的细胞生物学观点:通过区室化进行调节
Nat Rev Immunol. 2009 Aug;9(8):535-42. doi: 10.1038/nri2587. Epub 2009 Jun 26.
6
The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells.Toll样受体7/8激动剂瑞喹莫德可显著增强人急性髓系白血病细胞的免疫刺激能力。
Cancer Immunol Immunother. 2010 Jan;59(1):35-46. doi: 10.1007/s00262-009-0721-8. Epub 2009 May 16.
7
Role of atopic status in Toll-like receptor (TLR)7- and TLR9-mediated activation of human eosinophils.特应性状态在Toll样受体(TLR)7和TLR9介导的人嗜酸性粒细胞活化中的作用。
J Leukoc Biol. 2009 Apr;85(4):719-27. doi: 10.1189/jlb.0808494. Epub 2009 Jan 7.
8
Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia.细胞遗传学正常的急性髓系白血病中具有预后意义的基因表达
Semin Oncol. 2008 Aug;35(4):356-64. doi: 10.1053/j.seminoncol.2008.04.006.
9
Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines.全细胞癌症疫苗接种:从基于自体肿瘤和树突状细胞的疫苗到基于同种异体肿瘤和树突状细胞的疫苗。
Cancer Immunol Immunother. 2008 Oct;57(10):1569-77. doi: 10.1007/s00262-008-0536-z. Epub 2008 Jun 4.
10
Twelve immunotherapy drugs that could cure cancers.十二种可治愈癌症的免疫疗法药物。
Immunol Rev. 2008 Apr;222:357-68. doi: 10.1111/j.1600-065X.2008.00604.x.